We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.825
Bid: 2.70
Ask: 2.95
Change: 0.025 (0.89%)
Spread: 0.25 (9.259%)
Open: 2.80
High: 2.825
Low: 2.80
Prev. Close: 2.80
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of equity and Director/PDMR shareholdings

4 Feb 2019 16:20

RNS Number : 0270P
Brave Bison Group PLC
04 February 2019
 

4 February 2019

Brave Bison Group plc

("Brave Bison" or the "Company")

 

Issue of equity, Director/PDMR shareholdings and

change to total voting rights

 

Brave Bison Group plc (AIM: BBSN), the social video company, announces that application has been made for the admission to trading on AIM of 29,365,257 new ordinary shares of 0.1p each in the Company (the "New Ordinary Shares"). The New Ordinary Shares have been issued pursuant to the exercise today of restricted stock units ("RSUs") awarded to certain employees and directors in November 2017 under the Company's RSU Plan and of options granted in connection with the acquisition of Base79 Ltd in 2014.

 

Of the RSUs exercised today, the Company's executive directors have exercised 23,912,884 RSUs and therefore have today been issued New Ordinary Shares as follows:

 

Director

New Ordinary Shares issued

Total number of ordinary shares now held

 

 

Percentage of issued share capital now held

Claire Hungate

21,521,596

22,770,102

3.76

Paul Campbell-White

2,391,288

3,020,218

0.50

 

The New Ordinary Shares rank pari passu in all respects with the Company's existing ordinary shares and admission of the New Ordinary Shares to trading on AIM is expected to become effective on 8 February 2019 ("Admission").

 

Total Voting Rights

 

Following Admission, the issued share capital of the Company will consist of 605,505,287 ordinary shares of 0.1p each ("Ordinary Shares"), with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 605,505,287. From Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Brave Bison Group plc

Jack Bates, Communications Manager

Email: jackbates@bravebison.io

 

Allenby Capital Limited - AIM Nominated Adviser and Broker

Jeremy Porter / Asha Chotai

Tel: 020 3328 5656

 

Newgate Communications

Elisabeth Cowell / Robin Tozer/ Fiona Norman

bravebison@newgatecomms.com

Tel: 020 3757 6880

  About Brave Bison:

Brave Bison is a social video company, proudly working with some of the biggest brands and most followed YouTube and Facebook talent in the world. Clients include P&G, Shell, PUMA and Hyundai.

 

Brave Bison makes it simple for content owners, creators, brands, publishers and platforms to unlock the value of online video, whether on a licensed, ad-funded, direct to consumer or paid placement basis.

 

The business is based in two regions - Europe, with headquarters in London; and APAC, with offices in Singapore.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Claire Hungate

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Brave Bison plc

b)

 

LEI

 

213800BEII7EWIN8X308 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.1p

 

 

GB00BF8HJ774

b)

 

Nature of the transaction

 

Exercise of restricted stock units

c)

 

Price(s) and volume(s)

Price(s)

 

Volume(s)

0.1p exercise price

21,521,596

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

 

e)

 

Date of the transaction 

4 February 2019

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Paul Campbell-White

2

 

Reason for the notification

 

a)

 

Position/status

 

CFO

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Brave Bison plc

b)

 

LEI

 

213800BEII7EWIN8X308 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.1p

 

 

GB00BF8HJ774

b)

 

Nature of the transaction

 

Exercise of restricted stock units

c)

 

Price(s) and volume(s)

Price(s)

 

Volume(s)

0.1p exercise price

2,391,288

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

 

e)

 

Date of the transaction 

4 February 2019

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGGZVDRGLZM
Date   Source Headline
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSNotice of Results & Investor Presentation
10th Mar 20234:58 pmRNSHolding(s) in Company
9th Mar 202311:43 amRNSHolding(s) in Company
21st Feb 20231:34 pmRNSHolding(s) in Company
21st Feb 20231:33 pmRNSHolding(s) in Company
21st Feb 20231:32 pmRNSHolding(s) in Company
21st Feb 20231:30 pmRNSHolding(s) in Company
13th Feb 20235:50 pmRNSHolding(s) in Company
13th Feb 202310:23 amRNSHolding(s) in Company
7th Feb 20237:00 amRNSHolding(s) in Company
6th Feb 20235:28 pmRNSHolding(s) in Company
6th Feb 20235:04 pmRNSDirector/PDMR Shareholding
6th Feb 20231:06 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSAcquisition of Social Chain and Vendor Placing
14th Dec 20224:17 pmRNSHolding(s) in Company
7th Dec 202211:17 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSNew Financing Facility
22nd Sep 20227:00 amRNSHalf-year Report
16th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20223:17 pmRNSHolding(s) in Company
22nd Jul 20221:55 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSHalf Year Trading Update
11th Jul 20227:00 amRNSDirectorate Change
29th Jun 20225:04 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
6th Jun 20227:00 amRNSSignificant Contract Wins
27th May 20224:21 pmRNSNotice of AGM
29th Apr 20221:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.